Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.

HBeAg-negative chronic hepatitis B patients require long-term nucleos(t)ide analogues(NAs) because loss of surface antigen (HBsAg) is unusual. Low quantitative HBsAg (qHBsAg) levels can identify patients with higher probability of seroclearance. The aim of our study was to evaluate qHBsAg in HBeAg-n...

Full description

Bibliographic Details
Main Authors: Teresa Broquetas, Montserrat Garcia-Retortillo, Juan José Hernandez, Marc Puigvehí, Nuria Cañete, Susana Coll, Beatriz Cabrero, Maria Dolors Giménez, Ricard Solà, José A Carrión
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5708657?pdf=render

Internet

http://europepmc.org/articles/PMC5708657?pdf=render

Similar Items